Insiders · Profile

Mock James M

Chief Financial Officer at Moderna · Please See Remarks at Revvity. Filing since 2 Oct 2020. CIK 0001736359

MRNA Moderna Chief Financial Officer · 13 trades RVTY Revvity Please See Remarks · 3 trades

Company

Date

Role

Action

Shares

Amount

Of holding

10 Sep 2026

Chief Financial Officer

Sold on a plan

34,836

$4.69M

37.0%

29 Nov 2024

Chief Financial Officer

Sold on a plan

1,420

$60.76K

11.4%

7 Oct 2024

Chief Financial Officer

Sold on a plan

715

$42.99K

7.0%

29 Aug 2024

Chief Financial Officer

Sold on a plan

162

$12.64K

1.8%

28 Aug 2024

Chief Financial Officer

Sold on a plan

1,321

$104.88K

13.3%

8 Jul 2024

Chief Financial Officer

Sold on a plan

689

$81.47K

8.7%

3 Jun 2024

Chief Financial Officer

Sold on a plan

691

$97.24K

9.6%

29 May 2024

Chief Financial Officer

Sold on a plan

183

$26.44K

3.0%

28 May 2024

Chief Financial Officer

Sold on a plan

648

$105.28K

10.2%

8 Apr 2024

Chief Financial Officer

Sold on a plan

705

$71.86K

12.3%

29 Feb 2024

Chief Financial Officer

Sold on a plan

647

$61.19K

13.1%

8 Jan 2024

Chief Financial Officer

Sold on a plan

772

$84.73K

17.5%

6 Oct 2023

Chief Financial Officer

Sold on a plan

2,858

$292.95K

49.2%

24 Jun 2022

Please See Remarks

Sold, plan not stated

5,025

$731.09K

15.4%

20 Sep 2021

Please See Remarks

Sold, plan not stated

6,080

$1.12M

20.7%

2 Oct 2020

Please See Remarks

Sold, plan not stated

5,623

$699.58K

17.1%

16 decisions on file.